Stocktoria

Lifevantage Corp LFVN

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2012-09-12 · LEI

Lifevantage Corp financials (annual)

Revenue
$206.5M $199.5M $203.2M $226.0M $232.9M $220.2M $206.4M $213.4M $200.2M $228.5M 2016201720182019202020212022202320242025
Net income
$6.1M $1.6M $5.8M $7.4M $11.5M $12.9M $3.1M $2.5M $2.9M $9.8M 2016201720182019202020212022202320242025
Free cash flow
$5.5M $5.5M $8.6M $15.3M $15.6M $12.5M $6.4M $3.8M $10.0M $10.5M 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$228.5M$200.2M$213.4M$206.4M$220.2M$232.9M$226.0M$203.2M$199.5M$206.5M
Gross profit$183.7M$158.7M$170.0M$168.3M$182.0M$195.0M$188.0M$168.4M$166.0M$172.6M
R&D expense$1.4M$700,000$600,000$700,000$700,000$900,000$1.1M$1.2M$1.1M$1.0M
SG&A expense$69.2M$68.5M$71.1M$63.4M$60.8M$67.9M$69.6M$59.8M$64.9M$56.1M
Operating income$12.2M$4.3M$4.3M$7.6M$17.6M$15.5M$9.8M$10.3M$4.4M$13.4M
Interest expense-$430,000-$198,000$10,000$17,000$120,000$323,000$456,000$570,000$3.3M
Income tax$2.4M$1.4M$1.5M$1.6M$4.3M$3.1M$1.8M$3.8M$1.3M$2.6M
Net income$9.8M$2.9M$2.5M$3.1M$12.9M$11.5M$7.4M$5.8M$1.6M$6.1M
EPS (diluted)$0.75$0.23$0.20$0.24$0.90$0.79$0.50$0.41$0.11$0.42
Operating cash flow$11.9M$12.2M$6.8M$8.0M$16.3M$18.3M$17.8M$13.3M$6.6M$6.0M
Free cash flow$10.5M$10.0M$3.8M$6.4M$12.5M$15.6M$15.3M$8.6M$5.5M$5.5M
Cash & equivalents$20.2M$16.9M$21.6M$20.2M$23.2M$22.1M$18.8M$16.7M$11.5M$7.9M
Inventory$20.7M$15.1M$16.1M$16.5M$16.1M$13.9M$13.8M$13.6M$16.6M$25.1M
Total assets$72.0M$60.3M$66.1M$70.7M$78.7M$58.9M$55.3M$51.1M$45.2M$50.9M
Total liabilities$37.3M$34.3M$31.5M$39.2M$41.9M$25.6M$28.1M$29.2M$30.7M$40.2M
Shareholders' equity$34.6M$26.0M$34.6M$31.5M$36.8M$33.3M$27.2M$21.9M$14.5M$10.6M

Growth · year-over-year · Revenue CAGR 1.1%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth+14.2%-6.2%+3.4%-6.3%-5.5%+3.1%+11.2%+1.9%-3.4%+8.5%
Net income growth+233.8%+15.6%-18.6%-75.8%+11.6%+55.5%+29.0%+258.3%-73.7%-14.3%
EPS growth+226.1%+15.0%-16.7%-73.3%+13.9%+58.0%+22.0%+272.7%-73.8%-16.0%
Free cash flow growth+5.6%+164.6%-41.5%-48.7%-19.9%+2.4%+77.6%+55.3%+1.2%-54.6%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.